OPCON-A
RegisteredUS US · App #74509424 · Reg #1993877
Owned by
BAUSCH & LOMB INCORPORATEDApplication date
1994-04-06
Registration date
1996-08-13
Published date
1995-07-04
First use date
—
Renewal date
2016-08-13
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
006018044046051052
Current owners
Applicants
- BAUSCH & LOMB INCORPORATED
Previous owners
- BAUSCH & LOMB INCORPORATED
- BAUSCH & LOMB INCORPORATED
Correspondence
- [Nancy L. Rowe] Bausch + Lomb
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
27
Security: 8
Renewals
3
Prosecution events
73
Renewals & Maintenance
| Kind | Effective date | Status |
|---|---|---|
| Earliest Filing Date | 2025-08-13 | — |
| Latest Filing Date Without Additional Fee | 2026-08-13 | — |
| Latest Filing Date With Additional Fee | 2027-02-16 | — |
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2025-11-07 | RELEASE OF SECURITY INTEREST IN TRADEMARKS AT REEL/FRAME 6280/0211 | THE BANK OF NEW YORK MELLON → INKINE PHARMACEUTICAL COMPANY, INC.., SALIX PHARMACEUTICALS, LTD., COMMONWEALTH LABORATORIES, LTD., ONPHARMA INC., UCYCLYD PHARMA, INC., VALEANT CANADA LP, ALDEN OPTICAL LABORATORIES, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, DOW PHARMACEUTICAL SCIENCES, INC., PRECISION DERMATOLOGY, INC., VALEANT PHARMACEUTICALS IRELAND LIMITED, SOLTA MEDICAL, INC., VALEANT PHARMA POLAND SP. Z.O.O., VALEANT PHARMACEUTICALS INTERNATIONAL, ATON PHARMA, INC., SANTARUS, INC, BAUSCH & LOMB INCORPORATED, ORAPHARMA, INC., CORIA LABORATORIES, LLC, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., BAUSCH & LOMB PHARMA HOLDINGS CORP., PRIVATE FORMULA CORP., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, TECHNOLAS PERFECT VISION GMBH, OCEANSIDE PHARMACEUTICALS, INC., ECR PHARMACEUTICAL CO., INC., SALIX PHARMACEUTICALS, INC. | Release |
| 2025-08-13 | ASSIGNMENT OF SECURITY INTEREST IN TRADEMARKS PREVIOUSLY RECORDED AT REEL/FRAME (7717/0577) | CITIBANK, N.A., AS RESIGNING AGENT → JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | Security |
| 2025-06-26 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH + LOMB IRELAND LIMITED → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 5102/0628 | BARCLAYS BANK PLC, AS SUCCESSOR AGENT → BAUSCH & LOMB INCORPORATED | Release |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 6280/0114 | BARCLAYS BANK PLC → BAUSCH HEALTH IRELAND LIMITED, VALEANT PHARMA POLAND SP. ZO.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., VALEANT INTERNATIONAL (BARBADOS) SRL, BAUSCH HEALTH COMPANIES INC., CORIA LABORATORIES, LTD., VALEANT PHARMACEUTICALS IRELAND, SALIX PHARMACEUTICALS, LTD., ONPHARMA INC., UCYCLYD PHARMA, INC., BAUSCH HEALTH US, LLC, ALDEN OPTICAL LABORATORIES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, PRECISION DERMATOLOGY, INC., VALEANT PHARMACEUTICALS IRELAND LIMITED, SOLTA MEDICAL, INC., COMMONWEALTH LABORATORIES, LLC, VALEANT PHARMACEUTICALS NORTH AMERICA, VALEANT PHARMACEUTICALS INTERNATIONAL, INKINE PHARMACEUTICAL COMPANY, INC., ATON PHARMA, INC., EXZELL PHARMA INC., BAUSCH & LOMB INCORPORATED, ORAPHARMA, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., MEDICIS PHARMACEUTICAL CORPORATION, BAUSCH + LOMB IRELAND LIMITED, TECHNOLAS PERFECT VISION GMBH, SANTARUS, INC., PRIVATE FORMULA CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC. | Release |
| 2023-09-29 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 5439/0392) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 6280/0114) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7320/0509) | THE BANK OF NEW YORK MELLON → ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6111/0139) | THE BANK OF NEW YORK MELLON → BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6280/0211) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7630/0605) | THE BANK OF NEW YORK MELLON → ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6586/0877) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-05-10 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A. AS COLLATERAL AGENT | Transfer |
| 2022-02-10 | SECURITY AGREEMENT | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON | Transfer |
| 2021-06-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | CORRECTIVE ASSIGNMENT TO CORRECT THE REGISTRATION NUMBERS PREVIOUSLY RECORDED AT REEL: 006586 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., PRIVATE FORMULA CORP., BAUSCH HEALTH US, LLC, SANTARUS, INC., SOLTA MEDICAL, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., PRIVATE FORMULA CORP. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → BARCLAY'S BANK PLC, AS COLLATERAL AGENT | Security |
| 2017-07-17 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED → THE BANK OF NEW YORK MELLON | Security |
| 2015-01-08 | NOTICE OF SUCCESSION OF AGENCY | GOLDMAN SACHS LENDING PARTNERS, LLC → BARCLAYS BANK PLC, AS SUCCESSOR AGENT | Transfer |
| 2013-08-30 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED → GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT | Security |
| 2013-08-05 | RELEASE OF SECURITY INTEREST | CITIBANK, N.A. AS ADMINISTRATIVE AGENT → WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS, INC.), ISTA PHARMACEUTICALS, BAUSCH & LOMB INCORPORATED | Release |
| 2012-05-18 | SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED → CITIBANK N.A., AS ADMINISTRATIVE AGENT | Transfer |
| 2012-05-18 | RELEASE OF SECURITY INTEREST | CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH → BAUSCH & LOMB INCORPORATED | Release |
| 2007-10-26 | SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, B&L CRL INC., B&L CRL PARTNERS L.P., B & L DOMESTIC HOLDINGS CORP., B&L FINANCIAL HOLDINGS CORP., B&L SPAF INC., B&L VPLEX HOLDINGS, INC., BAUSCH & LOMB CHINA, INC., BAUSCH & LOMB INTERNATIONAL INC., BAUSCH & LOMB REALTY CORPORATION, BAUSCH & LOMB SOUTH ASIA, INC., BAUSCH & LOMB TECHNOLOGY CORPORATION, IOLAB CORPORATION, RHC HOLDINGS, INC., SIGHT SAVERS, INC., WILMINGTON MANAGEMENT CORP., WILMINGTON PARTNERS L.P., B&L MINORITY DUTCH HOLDINGS LLC → CREDIT SUISSE | Transfer |
Prosecution History
73 events| Date | Event |
|---|---|
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-09-10 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-08-14 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 2025-07-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-04-16 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2023-10-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-28 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-14 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-10-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2022-10-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2022-10-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2022-10-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2022-10-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2022-06-23 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-05-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-03-09 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2021-10-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-10-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-10-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-11-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2020-09-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-09-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-09-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-09-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-09-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-05-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-05-03 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-05-03 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2017-09-19 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2017-09-19 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2016-05-27 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 2016-05-27 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
| 2016-05-27 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 2016-05-27 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2016-03-13 | TEAS SECTION 8 & 9 RECEIVED |
| 2016-03-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2015-08-13 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 2015-01-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2013-12-27 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2013-12-27 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2013-12-27 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Showing first 50 of 73 events